Pulmocide
Series BPulmocide raised €28M in a Series B round in Mar 2017. The company is based in London, UK. Investors in the round: F-Prime Capital, Johnson & Johnson, Johnson & Johnson Innovation and 3 others. Data as of Nov 2026.
Amount raised
€28M
€27,700,000
Native amount
27,700,000 EUR
Stage
Series B
series b
Investors
6
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €28M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedF-Prime CapitalJohnson & JohnsonJohnson & Johnson InnovationSR OneSV Life SciencesTouchstone Innovations
Date
Mar 2017
Round type
series b
Amount (EUR)
€28M
Other rounds
same companyThis is the company's only recorded round.